Menu
Back to User profile » Professor Noel G McElvaney
Papers published by Professor Noel G McElvaney:
Physical Activity, Exercise Capacity and Sedentary Behavior in People with Alpha-1 Antitrypsin Deficiency: A Scoping Review
O'Shea O, Casey S, Giblin C, Stephenson A, Carroll TP, McElvaney NG, McDonough SM
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1231-1250
Published Date: 16 June 2023
The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
Dunlea DM, Fee LT, McEnery T, McElvaney NG, Reeves EP
Journal of Inflammation Research 2018, 11:123-134
Published Date: 26 March 2018
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
Chapman KR, Chorostowska-Wynimko J, Koczulla AR, Ferrarotti I, McElvaney NG
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:419-432
Published Date: 31 January 2018
Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes
Chotirmall SH, Al-Alawi M, McEnery T, McElvaney NG
Therapeutics and Clinical Risk Management 2015, 11:143-151
Published Date: 29 January 2015
Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
Bergin DA, Hurley K, Mehta A, Cox S, Ryan D, O’Neill SJ, Reeves EP, McElvaney NG
Journal of Inflammation Research 2013, 6:1-11
Published Date: 23 January 2013
The role of TIM-containing molecules in airway disease and their potential as therapeutic targets
Vega-Carrascal I, Reeves EP, McElvaney NG
Journal of Inflammation Research 2012, 5:77-87
Published Date: 14 August 2012
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
Caitriona McLean, Catherine M Greene, Noel G McElvaney
Biologics: Targets and Therapy 2009, 3:63-75
Published Date: 21 January 2009